Works matching IS 09441174 AND DT 2018 AND VI 53 AND IP 1


Results: 17
    1
    2
    3

    Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.

    Published in:
    2018
    By:
    • Masuda, Kazuhiko;
    • Ono, Atsushi;
    • Aikata, Hiroshi;
    • Kawaoka, Tomokazu;
    • Nelson Hayes, C.;
    • Teraoka, Yuji;
    • Daijo, Kana;
    • Nakamura-Inagaki, Yuki;
    • Morio, Kei;
    • Fujino, Hatsue;
    • Kan, Hiromi;
    • Uchida, Takuro;
    • Masaki, Keiichi;
    • Kobayashi, Tomoki;
    • Nakahara, Takashi;
    • Makokha, Grace Naswa;
    • Zhang, Yizhou;
    • Nagaoki, Yuko;
    • Miki, Daiki;
    • Tsuge, Masataka
    Publication type:
    journal article
    4

    Erratum to: Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.

    Published in:
    2018
    By:
    • Masuda, Kazuhiko;
    • Ono, Atsushi;
    • Aikata, Hiroshi;
    • Kawaoka, Tomokazu;
    • Nelson Hayes, C.;
    • Teraoka, Yuji;
    • Daijo, Kana;
    • Nakamura-Inagaki, Yuki;
    • Morio, Kei;
    • Fujino, Hatsue;
    • Kan, Hiromi;
    • Uchida, Takuro;
    • Masaki, Keiichi;
    • Kobayashi, Tomoki;
    • Nakahara, Takashi;
    • Makokha, Grace Naswa;
    • Zhang, Yizhou;
    • Nagaoki, Yuko;
    • Miki, Daiki;
    • Tsuge, Masataka
    Publication type:
    journal article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17